Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MESO | AZN | AMGN | GILD | BMY |
| Company | Mesoblast Ltd ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 15.98 | 196.55 | 344.09 | 133.69 | 59.40 |
| High | 16.00 | 196.65 | 347.68 | 134.08 | 59.70 |
| Low | 15.63 | 195.45 | 343.52 | 131.34 | 58.68 |
| Latest | 15.71 | 195.67 | 343.76 | 131.76 | 58.90 |
| Change | -0.47 | -0.11 | -1.10 | -1.53 | -0.49 |
| % Change | -2.90% | -0.06% | -0.32% | -1.15% | -0.83% |
| Volume | 77,606 | 956,059 | 740,065 | 2,674,458 | 3,115,849 |
| 20-Day Average Volume | 240,017 | 1,836,677 | 2,366,421 | 5,038,644 | 9,397,892 |
| Previous Close | 16.18 | 195.78 | 344.86 | 133.29 | 59.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.17 | 198.82 | 349.51 | 138.14 | 59.17 |
| 20-Day Raw Stochastic | 67.17% | 52.26% | 38.67% | 0.78% | 33.17% |
| 20-Day Relative Strength | 51.20 | 48.29 | 43.83 | 36.96 | 49.70 |
| Weighted Alpha | +8.72 | +38.18 | +21.09 | +22.94 | +26.57 |
| Today's Opinion | 40% Sell | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 24% Sell | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Last Month's Opinion | 72% Sell | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.25% since 04/15/26 | -2.79% since 04/15/26 | -1.07% since 04/15/26 | -5.85% since 04/15/26 | +1.71% since 04/15/26 |
| Low | 15.63 on 04/22/26 | 195.45 on 04/22/26 | 340.06 on 04/21/26 | 131.51 on 04/22/26 | 57.66 on 04/16/26 |
| High | 16.89 on 04/20/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +9.40% since 03/20/26 | +6.54% since 03/20/26 | -0.95% since 03/20/26 | -4.09% since 03/20/26 | +2.44% since 03/20/26 |
| Low | 13.30 on 04/07/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.51 on 04/22/26 | 56.45 on 03/24/26 |
| High | 16.89 on 04/20/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -16.30% since 01/22/26 | +6.66% since 01/22/26 | -0.74% since 01/22/26 | +0.35% since 01/22/26 | +7.17% since 01/22/26 |
| Low | 13.30 on 04/07/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 131.00 on 01/23/26 | 54.21 on 01/29/26 |
| High | 19.34 on 01/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -8.56% since 10/22/25 | +17.22% since 10/22/25 | +16.39% since 10/22/25 | +8.34% since 10/22/25 | +32.64% since 10/22/25 |
| Low | 13.30 on 04/07/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 21.50 on 01/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,089,744 | 303,636,768 | 186,115,760 | 165,442,480 | 121,258,640 |
| Shares Outstanding, K | 129,156 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 17,200,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -102,140,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,930,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -21,920,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.19 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/06/19 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.03 | 16.67 | 9.61 |